Delta-Fly Pharma (TSE:4598) Total Liabilities : 円110.31 Mil (As of Sep. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Delta-Fly Pharma Total Liabilities?

Delta-Fly Pharma's Total Liabilities for the quarter that ended in Sep. 2024 was 円110.31 Mil.

Delta-Fly Pharma's quarterly Total Liabilities increased from Dec. 2023 (円91.00 Mil) to Mar. 2024 (円241.50 Mil) but then declined from Mar. 2024 (円241.50 Mil) to Sep. 2024 (円110.31 Mil).

Delta-Fly Pharma's annual Total Liabilities increased from Mar. 2022 (円91.19 Mil) to Mar. 2023 (円115.62 Mil) and increased from Mar. 2023 (円115.62 Mil) to Mar. 2024 (円241.50 Mil).

Delta-Fly Pharma Total Liabilities Historical Data

The historical data trend for Delta-Fly Pharma's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Delta-Fly Pharma Total Liabilities Chart

Delta-Fly Pharma Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Total Liabilities

Get a 7-Day Free Trial

105.94

82.46

91.19

115.62

241.50

Delta-Fly Pharma Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Sep24
Total Liabilities	Get a 7-Day Free Trial															64.88	87.94	91.00	241.50	110.31

Delta-Fly Pharma Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Delta-Fly Pharma's Total Liabilities for the fiscal year that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	241.498	+	(0	+	-0.00099999999997635
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	241.50

Total Liabilities	=	Total Assets (A: Mar. 2024 )	-	Total Equity (A: Mar. 2024 )
	=	1474.155	-	1232.658
	=	241.50

Delta-Fly Pharma's Total Liabilities for the quarter that ended in Sep. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	110.311	+	(0	+	-0.0010000000000048
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	110.31

Total Liabilities	=	Total Assets (Q: Sep. 2024 )	-	Total Equity (Q: Sep. 2024 )
	=	425.82	-	315.51
	=	110.31

Delta-Fly Pharma Total Liabilities Related Terms

Thank you for viewing the detailed overview of Delta-Fly Pharma's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Delta-Fly Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Delta-Fly Pharma Inc (TSE:4598) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

Miyajima Kinno 37-5, Tokushima Prefecture, Kawauchi Town, Tokushima, JPN, 771-0116

Website

http://www.delta-flypharma.co.jp

Delta-Fly Pharma Inc is a Japan-based company mainly engaged in the discovery and development of gentle anti-cancer agents with module technology.

Delta-Fly Pharma Headlines

No Headlines